Provided by Tiger Fintech (Singapore) Pte. Ltd.

Johnson & Johnson

193.22
+1.100.57%
Post-market: 192.00-1.2200-0.63%19:59 EDT
Volume:7.76M
Turnover:1.50B
Market Cap:465.34B
PE:18.67
High:193.60
Open:192.50
Low:191.68
Close:192.12
52wk High:194.40
52wk Low:140.68
Shares:2.41B
Float Shares:2.40B
Volume Ratio:0.76
T/O Rate:0.32%
Dividend:5.08
Dividend Rate:2.63%
EPS(TTM):10.35
EPS(LYR):5.84
ROE:33.80%
ROA:7.61%
PB:5.93
PE(LYR):33.07

Loading ...

This 2.7%-Yielding Dividend King Remains One of the Healthiest Income Stocks You Can Buy

Motley Fool
·
Oct 15

J&J : TD Cowen Raises Target Price to $222 From $185

THOMSON REUTERS
·
Oct 15

Johnson & Johnson Reports Strong Q3 2025 Performance

TIPRANKS
·
Oct 15

Johnson & Johnson’s Earnings Call Highlights Growth and Strategy

TIPRANKS
·
Oct 15

Positive Report for Johnson & Johnson (JNJ) from CFRA

TIPRANKS
·
Oct 15

Johnson & Johnson price target raised to $215 from $213 at Citi

TIPRANKS
·
Oct 15

BUZZ-U.S. STOCKS ON THE MOVE-Spyre Therapeutics, Astria, Walmart

Reuters
·
Oct 15

Sector Update: Health Care Stocks Higher Tuesday Afternoon

MT Newswires Live
·
Oct 15

TD Cowen Raises Johnson & Johnson Price Target to $222 From $185, Maintains Buy Rating

MT Newswires Live
·
Oct 15

Johnson & Johnson’s Strong Q3 Performance and Strategic Initiatives Drive Buy Rating

TIPRANKS
·
Oct 15

Johnson & Johnson Is Maintained at Buy by UBS

Dow Jones
·
Oct 15

Top Midday Stories: Big Banks Kick Off Earnings Season; Johnson & Johnson to Spin Off Orthopedics Business

MT Newswires Live
·
Oct 14

Johnson & Johnson Shares Reverse Premarket Gains; Last Down 1.4%

THOMSON REUTERS
·
Oct 14

UBS Adjusts Johnson & Johnson Price Target to $214 From $190, Maintains Buy Rating

MT Newswires Live
·
Oct 14

BRIEF-JNJ CFO Says Expect Rulings On Certain Legal Motions Pending In Talc Litigation By Q1 2026

Reuters
·
Oct 14

Jnj CFO Says 2026 Revenue Growth in Total Expected to Exceed 5%, Above Current Street Estimates

THOMSON REUTERS
·
Oct 14

Jnj CFO Joseph Wolk Says Expect Rulings on Certain Legal Motions Pending in Talc Litigation by Q1 2026: Conf Call

THOMSON REUTERS
·
Oct 14

Johnson & Johnson Q3 Results Beat Expectations, Plans Orthopedic Business Spinoff Amid Trump Drug Pricing Pressure

Deep News
·
Oct 14

BUZZ-U.S. STOCKS ON THE MOVE-Goldman Sachs, Domino's Pizza, Pattern Group

Reuters
·
Oct 14

Johnson & Johnson Raises Full-Year Sales Outlook and Plans Orthopedics Business Spinoff

Stock News
·
Oct 14